Form 4: SeaStar Medical Director Jennifer Baird Acquires 10,000 Shares
SEC Form 4 Filing
Director Jennifer Baird purchased 10,000 shares of SeaStar Medical Holding Corp at a weighted average price of $1.2815 on May 20, 2025.
Summary
- On May 20, 2025, Jennifer Baird, a director of SeaStar Medical Holding Corp, acquired 10,000 shares of common stock.
- The shares were purchased at a weighted average price of $1.2815, with individual transaction prices ranging from $1.27 to $1.29.
- Following the transaction, Ms. Baird directly owns 10,000 shares of SeaStar Medical Holding Corp.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a routine disclosure of insider trading. The director's purchase is a mildly positive signal, but not significantly impactful.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This is a standard disclosure of insider trading activity, which is common in the healthcare industry.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/20/2025 | Date of transaction: Jennifer Baird purchased 10,000 shares of SeaStar Medical Holding Corp. |
| 05/22/2025 | Date of signature on the SEC Form 4. |
Keywords
SeaStar Medical Holding Corp, Jennifer Baird, Director, Share Purchase, ICU, Common Stock, SEC Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.